Log In
Print this Print this

BuTab, BuTab ER, buprenorphine (REL-1028)

Also known as: formerly TQ-1028

  Manage Alerts
Collapse Summary General Information
Company Relmada Therapeutics Inc.
DescriptionExtended-release, enteric-coated, oral formulation of the opioid analgesic buprenorphine
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today